Simplex Trading
MDGL icon

Simplex Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History

Simplex Trading’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,179
Closed -$332K – 9174
2024
Q3 		$250K Sell
1,179
-2,393
-67% -$612K ﹤0.01% 4304
2024
Q2 		$1M Buy
3,572
+2,979
+502% +$709K ﹤0.01% 2910
2024
Q1 		$158K Sell
593
-3,341
-85% -$787K ﹤0.01% 5095
2023
Q4 		$910K Sell
3,934
-1,702
-30% -$298K ﹤0.01% 3087
2023
Q3 		$823K Sell
5,636
-17,006
-75% -$3.2M ﹤0.01% 2876
2023
Q2 		$5.23M Buy
22,642
+10,278
+83% +$2.78M ﹤0.01% 1283
2023
Q1 		$3M Buy
+12,364
New +$3.37M ﹤0.01% 1627
2022
Q4 		– Sell
-4,850
Closed -$474K – 9900
2022
Q3 		$315K Sell
4,850
-557
-10% -$38.7K ﹤0.01% 4020
2022
Q2 		$387K Sell
5,407
-5,014
-48% -$369K ﹤0.01% 3770
2022
Q1 		$1.02M Buy
10,421
+5,571
+115% +$470K ﹤0.01% 2891
2021
Q4 		$410K Sell
4,850
-11,364
-70% -$934K ﹤0.01% 4086
2021
Q3 		$1.61M Buy
16,214
+51
+0.3% +$4.41K ﹤0.01% 2444
2021
Q2 		$1.57M Buy
16,163
+11,313
+233% +$1.34M ﹤0.01% 2498
2021
Q1 		$567K Hold
4,850
– – ﹤0.01% 3190
2020
Q4 		$539K Sell
4,850
-4,739
-49% -$579K ﹤0.01% 3320
2020
Q3 		$1.14M Sell
9,589
-20,347
-68% -$2.21M ﹤0.01% 2089
2020
Q2 		$3.39M Buy
29,936
+4,637
+18% +$456K 0.01% 1104
2020
Q1 		$1.69M Buy
25,299
+17,158
+211% +$1.43M ﹤0.01% 1414
2019
Q4 		$741K Buy
8,141
+1,084
+15% +$105K ﹤0.01% 2363
2019
Q3 		$608K Buy
7,057
+698
+11% +$65.5K ﹤0.01% 2411
2019
Q2 		$666K Buy
6,359
+2,557
+67% +$274K ﹤0.01% 2306
2019
Q1 		$476K Sell
3,802
-5
-0.1% -$622 ﹤0.01% 2712
2018
Q4 		$429K Buy
3,807
+2,722
+251% +$421K ﹤0.01% 2369
2018
Q3 		$232K Buy
+1,085
New +$272K ﹤0.01% 3484
2016
Q2 		– Sell
-11
Closed – – 6186
2016
Q1 		$0 Buy
+11
New +$92 ﹤0.01% 5957
2015
Q3 		– Sell
-116
Closed -$8.37K – 5893
2015
Q2 		$9K Buy
116
+86
+287% +$7.22K ﹤0.01% 3154
2015
Q1 		$2K Buy
30
+1
+3% +$86 ﹤0.01% 4140
2014
Q4 		$3K Buy
+29
New +$3K ﹤0.01% 3485

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's MDGL Position: Q4 2024 in Review

Simplex Trading sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2024, closing a stake of 1,179 shares — an estimated $332K sold.

Simplex Trading first reported a position in MDGL in Q4 2014 and held it in 28 quarters. The position peaked at $5.23M in Q2 2023. 283 funds tracked by Wall St. Rank hold MDGL as of Q4 2024.

  • Simplex Trading reported no remaining Madrigal Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Simplex Trading sold 1,179 Madrigal Pharmaceuticals shares in Q4 2024, an estimated $332K.
  • Simplex Trading first reported a position in Madrigal Pharmaceuticals in Q4 2014 and held it in 28 quarters.
  • Simplex Trading's Madrigal Pharmaceuticals position peaked at $5.23M in Q2 2023.
  • 283 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.